Latest
State-of-the-art research facility takes shape
Related articles:
Infant leukemia: A team approach
Among all childhood cancers, leukemia in infancy is rare and challenging for researchers and doctors tasked with understanding causes and finding more successful treatments. Although… Read More
Beating a Main Cause of Death from Blood or Marrow Transplant
John Hallberg | As a non-scientist, it is a thrill for me to work with some of the brightest cancer researchers and clinicians in the… Read More
DNA-on-a-stick
Dr. Logan Spector, an associate professor of pediatrics at the University of Minnesota and leading epidemiologist, is working to develop a better understanding of the… Read More
From University of Minnesota Academic Health Center
The Cancer and Cardiovascular Research Building is the final landmark in the U of M’s Biomedical Discovery District (BDD) — the result of a $292 million funding program approved by the state of Minnesota in 2008. When complete in spring 2013, the cancer/cardio research building will bring top researchers together across disciplines to discover the next wave of cancer and cardiovascular treatments and therapies.
Researchers from across the Academic Health Center, including the Lillehei Heart Institute and Masonic Cancer Center, will occupy the new building. Cancer researchers plan to study chemical biology focusing on chemical carcinogens as a cause of cancer, and also want to build new models to find new therapeutic strategies to fight cancer. Cardiac researchers plan to study heart regeneration and development, muscular dystrophy, congenital heart medicine and genomics.
As the gateway to the BDD, the new cancer/cardio building will be publicly accessible, allowing visitors to interact with and get an up-close look at the research occurring across the district.
The long-term vision for the district includes additional University facilities as well as private sector partners.
University cardiovascular and oncology physician-researchers have a legacy of medical “firsts” that revolutionized medicine and changed medicine’s standard of care.
The first open-heart procedure was performed at the U of M, as was the world’s first bone marrow transplant. Other firsts include the first transplant to treat a patient with lymphoma, the first transplant to treat an inherited metabolic disease and the world’s first umbilical cord blood transplant performed using pre-implantation genetic testing to ensure a perfect tissue match.
“Simply put, basic science researchers plus clinical researchers equals new medical treatment. And flexible laboratory space in the Biomedical Discovery District provides a way for them to work side by side, learning from each other, “ said Aaron Friedman, vice president for Health Sciences and dean of the medical school of the University of Minnesota. “This type of translational research bridges the gap between basic science research and breakthrough therapies – propelling discoveries to become treatments sooner and more efficiently.”
You may also be interested in:
Ryan’s Story: Surviving Acute Myelogenous Leukemia
After the sniffles turned into a raging fever, his pediatrician decided to test a blood sample. The results were absolutely devastating – Ryan had leukemia. Read More
Event Sponsorships
Corporate sponsorships are available at various levels for Children’s Cancer Research Fund events. Each of these events can provide a mutually beneficial marketing relationship along… Read More